NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Technology and Digital Health > Study challenges idea of clinically significant mid-pregnancy drop in blood pressure

Study challenges idea of clinically significant mid-pregnancy drop in blood pressure

28 April 2021 · Listed under Technology and Digital Health

An international study involving NIHR Oxford BRC researchers has shown where normal blood pressure in pregnancy should be across the world and when clinicians should react because it is abnormal.

Photo by freestocks on Unsplash

The study’s findings, published in PLOS Medicine, provide international, gestational age-specific centiles and limits of acceptable change to facilitate earlier recognition of deteriorating health in pregnant women.

“These centiles challenge the idea of a clinically significant mid-pregnancy drop in blood pressure,” said one of the authors, Prof Peter Watkinson, joint clinical lead for the Critical Care Research Group at the University of Oxford’s Nuffield Department of Clinical Neurosciences.

“We hope this international study will help to improve diagnosis of illnesses affecting blood pressure in pregnancy,” said Prof Watkinson, the Oxford BRC’s Joint Theme Lead for Technology and Digital Health.

The purpose of the study was to identify internationally applicable gestational age-specific centiles for blood pressure in clinical practice to determine when women have left the ‘normal’ range.

As part of the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) Project, the research team recruited 4,607 healthy women across eight countries: Brazil, China, India, Italy, Kenya, Oman, the United Kingdom and the United States.

The researchers found that, on average, systolic blood pressure rose by around 8 mmHg (millimetres of mercury, the standard measurement for blood pressure) between 12 and 40 weeks’ gestation, with no decrease in mid-pregnancy. Diastolic blood pressure decreased slightly between 12 and 19 weeks, rising thereafter until 40 weeks’ gestation.

At any gestational age, systolic blood pressure fell by more than 14 mmHg and diastolic blood pressure by more than 11 mmHg from baseline in fewer than 10% of women. Fewer than 10% of women increased their systolic blood pressure by more than 24 mmHg or diastolic blood pressure by more than 18 mmHg at any gestational age.

← Oxford academics named NIHR Senior Investigators
Oxford wins government funding to evaluate prostate cancer detection system →

News

  • Study highlights ongoing COVID-19 risk in some cancer patients despite vaccination 24 May 2022
  • BRC study outlines researchers training needs and barriers 20 May 2022
  • Three new Blood and Transplant Research Units created in Oxford 18 May 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre